SOURCE: Xtalks

Xtalks Webinars

November 30, 2015 15:00 ET

Top News Stories You Might Have Missed From Xtalks

Xtalks Provides Current Articles Daily in the Life Science Industry

TORONTO, ON--(Marketwired - November 30, 2015) - Check out all news stories here: Subscribe to our weekly newsletter:

Immunotherapy Safety Trial For Type 1 Diabetes Deemed A Success --
(Nov 30) Researchers at the University of California-San Francisco (UCSF) led the first US safety trial of immunotherapy for patients with type 1 diabetes, and found that trial participants experienced no serious adverse reactions to the treatment.

Dr. Reddy's Laboratory Receives FDA Warning Letter --
(Nov 30) India-based drugmaker Dr. Reddy's Laboratories has received a warning letter in which the US Food and Drug Administration (FDA) cites incidents of data manipulation, and potential contamination issues.

Turing Pharmaceuticals Won't Budge on Price of Daraprim --
(Nov 26) Turing Pharmaceuticals -- and controversial CEO Martin Shkreli -- stirred up the drug pricing debate earlier this year when they raised the price of a decades-old antiparasitic medication by over 5,000 percent.

Debiotech Partners With Swiss Researchers To Develop Artificial Pancreas --
(Nov 26) Swiss medical device company Debiotech is set to develop a novel artificial pancreas for diabetic patients, in collaboration with Swiss academics.

Gene Editing Mosquitoes May Stop Spread Of Malaria --
(Nov 25) Using a gene editing technique called CRISPR, the researchers generated a new strain of mosquito which is capable of transmitting malaria-resistance genes to their offspring.

Ingestible Sensor Monitors Vital Signs --
(Nov 25) Researcher at the Massachusetts Institute of Technology (MIT) have developed a new ingestible medical device which measures breathing rate and heart rate from inside a patient's body.

Update: Pfizer and Allergan Finalize Merger --
(Nov 24) The $160 billion agreement between US-based Pfizer and Ireland-based Allergan has officially been made, according to a statement released by the companies on Monday.

Update: KaloBios Saved From Shut-Down By Turing Pharma's Martin Shkreli --
(Nov 24) The company had already hired a liquidation consultant when controversial CEO of Turing Pharmaceuticals, Martin Shkreli, swooped in and purchased a controlling stake of KaloBios.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit

Contact Information